Clinical Trial Update: Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating short-term linvoseltamab on top of chronic dupilumab in adults with severe IgE-mediated food allergy. The study is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Food Allergy

Drugs mentioned

• Dupilumab (dupilumab)
• Linvoseltamab

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Food Allergy | Phase 1 | Status: RECRUITING